[ad_1]
The Apple Watch Series 6 is a “reliable way” to monitor oxygen saturation in patients with lung disease, according to a study from the University of Sao Paulo, which may help in future medical treatments.
The Apple Watch Series 6 introduced a blood oxygen sensor into the wearable device, giving users a better idea of their overall fitness. In one study, it appears that the addition of Apple’s sensors could have serious medical applications.
The study by the Brazilian University of Sao Paulo, published in Nature Magazine and spotted by 9to5Mac place the Apple Watch Series 6 against a pair of commercial pulse oximeters. Approximately 100 patients from an outpatient pulmonary clinic with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) were analyzed with the devices.
“Strong positive correlations” have been observed between the Apple Watch and commercial oximeters for evaluating heart rate measurements and oximetry. While the Apple Watch tended to report higher oximetry numbers on average, the study “did not see significant differences” in blood oxygen and heart rate numbers.
The study concludes that “our results indicate that the Apple Watch 6 [sic] is a reliable way to obtain heart rate and SPO2 in patients with lung disease under controlled conditions. Advances in smart watch technology continue to improve and studies to assess the accuracy and reliability of various types of disease should be conducted. “
Apple also conducts its own studies in various medical fields, in partnership with outside organizations. In April, he teamed up with the University of Washington and the Seattle Flu Study to see if the Apple Watch could predict illnesses, like fu, or other respiratory conditions.
In September, Biogen launched a study with Apple and UCLA on how the Apple Watch could detect symptoms of neurological diseases, including dementia and depression.
[ad_2]
Source link